BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 30081891)

  • 1. Dendritic cells pulsed with generated tumor cell lysate from Phyllanthus amarus Schum. & Thonn. induces anti-tumor immune response.
    Mohamed SIA; Jantan I; Nafiah MA; Seyed MA; Chan KM
    BMC Complement Altern Med; 2018 Aug; 18(1):232. PubMed ID: 30081891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages.
    Harikrishnan H; Jantan I; Haque MA; Kumolosasi E
    BMC Complement Altern Med; 2018 Jul; 18(1):224. PubMed ID: 30045725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive effects of the standardized extract of Phyllanthus amarus on cellular immune responses in Wistar-Kyoto rats.
    Ilangkovan M; Jantan I; Mesaik MA; Bukhari SN
    Drug Des Devel Ther; 2015; 9():4917-30. PubMed ID: 26347462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous extract of Phyllanthus niruri (Euphorbiaceae) enhances the phenotypic and functional maturation of bone marrow-derived dendritic cells and their antigen-presentation function.
    Nworu CS; Akah PA; Okoye FB; Esimone CO
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):393-401. PubMed ID: 20095802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
    Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
    Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
    Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
    J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
    von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
    J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells.
    Liang W; Wang XF
    Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC gene-modified dendritic cells mediate T cell-dependent anti-gastric cancer immune responses in vitro.
    Xue G; Cheng Y; Ran F; Li X; Huang T; Yang Y; Zhang Y
    Oncol Rep; 2013 Feb; 29(2):595-604. PubMed ID: 23229068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of histamine and its antagonists on murine T-cells and bone marrow-derived dendritic cells.
    Hu X; Zafar MI; Gao F
    Drug Des Devel Ther; 2015; 9():4847-60. PubMed ID: 26346531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.